WINDLAS

Windlas Biotech Ltd.

NSE: WINDLAS

BSE: 543329

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

945.40-3.8 (-0.40%)

12 Oct, 2:59 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

82.5 / 100

Value Score

53.4 / 100

Price Momentum Score

74.3 / 100

QVM Score

89.2 / 100

Key Metrics

Market Cap

1958.77

P/E (TTM)

29.48

P/B

3.37

P/S (TTM)

2.08

EV/EBITDA

16.35

CAPE (5Y)

36.31

ROE (TTM)

12.23

ROCE (TTM)

12.82

ROA (TTM)

7.97

Avg 3Y ROE

12.88

Earnings 3Y CAGR

14.07

Sales 3Y CAGR

20.54

Sales 5Y CAGR

16.15

Debt/Equity

0.06

Consensus TP

Strong Buy %

Promoter Holding

63.31

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Windlas Biotech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 74.3 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

74.3 / 100

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 18.53% for 12-month ended 30 Jun 2026 and the growth was 7.85 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 18.53

-99.6111701.8

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.06 as on 30 Jun 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 4 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at same valuation levels as industry median P/E

PE TTM of 29.48 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at -6.35%

What is P/E Ratio?

Median: 31.48

Value 29.48

-0.8734.68

Low but stable operating margin

The company reported low operating margin of 7.9% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -97 bps from 1 year ago

What is Operating profit margin?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of 1.11% for 12-month ended 30 Jun 2026 and the growth was 6.34 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.66%

What is Dividend yield?

Neutral

Moderate and stable ROE

The company reported moderate ROE of 12.23% for 12-month ended 30 Jun 2026 and ROE declined marginally by -52 bps from 1 year ago

What is ROE (FY)?

Company's earnings are of moderate quality

Earnings quality score of 67.6 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

67.6 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Windlas Biotech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Windlas Biotech Ltd. Shareholding Pattern

Quarterly breakdown of Windlas Biotech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	0.00	100.00	88.00	88.00	88.00	78.00	59.95	59.95	59.95	59.95	59.95	60.75	62.38	62.82	62.82	62.82	62.82	62.51	62.51	62.51	62.34	62.34	61.99	61.99	61.90	63.31
Indian Promoter	0.00	100.00	88.00	88.00	88.00	78.00	59.95	59.95	59.95	59.95	59.95	60.75	62.38	62.82	62.82	62.82	62.82	62.51	62.51	62.51	62.34	62.34	61.99	61.99	61.90	63.31
Foreign Promoter	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	0.00	0.00	0.00	0.00	22.00	16.99	15.07	13.23	15.44	13.33	13.65	12.93	12.33	12.33	13.06	13.00	11.94	11.58	11.81	12.41	12.65	12.54	12.37	12.41	11.88
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	0.00	9.31	9.90	9.50	11.90	10.89	11.39	10.64	10.51	10.43	10.40	10.37	8.70	7.57	7.11	6.70	6.80	6.39	6.63	7.08	5.76
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.12	0.12	0.12	0.04	0.04	0.04	0.04	0.04	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	6.24	3.77	3.40	3.21	2.19	1.45	1.32	0.80	0.80	1.35	1.18	1.59	2.00	1.55	1.52	1.44	1.11	0.93	0.60	2.04
Other Institutions	0.00	0.00	0.00	0.00	0.00	22.00	1.32	1.28	0.21	0.21	0.21	0.77	0.93	0.98	1.05	1.27	1.45	1.65	2.01	3.15	4.19	4.42	5.05	4.81	4.72	4.08
Non-Institution	100.00	0.00	12.00	12.00	12.00	0.00	23.06	24.99	26.82	24.62	26.72	25.59	24.69	24.85	24.86	24.12	24.19	25.55	25.91	25.68	25.25	25.01	25.47	25.64	25.70	24.80
Bodies Corporate	0.00	0.00	0.00	0.00	12.00	0.00	-	1.35	1.56	1.62	1.98	1.47	1.07	1.17	1.07	0.82	1.08	1.59	1.78	1.86	1.82	1.89	1.60	1.39	1.28	1.35
Others (incl. Retail) No. of shareholders	100.00 7	0.00 5	12.00 6	12.00 6	0.00 5	0.00 5	23.06 1,08,790	23.64 99,108	25.26 91,974	23.00 88,603	24.74 86,649	24.12 82,548	23.62 79,097	23.68 75,313	23.79 68,656	23.30 61,758	23.11 51,133	23.96 45,655	24.13 45,504	23.82 46,376	23.43 46,176	23.12 45,670	23.87 45,225	24.25 45,252	24.42 44,571	23.45 44,768

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Biotech	2.81%	11 / 15

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Windlas Biotech Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
AJAY KUMAR AGGARWAL	20 Feb 2025	buy	₹ 787.42	1.45 lac	₹ 11.42 cr
SAMVITTI CAPITAL PRIVATE LIMITED ACTIVE ALPHA MULTICAP	19 Feb 2025	sell	₹ 683.49	1.15 lac	₹ 7.89 cr
GRAVITON RESEARCH CAPITAL LLP	01 Mar 2024	buy	₹ 565.96	1.11 lac	₹ 6.26 cr
GRAVITON RESEARCH CAPITAL LLP	01 Mar 2024	sell	₹ 564.94	1.11 lac	₹ 6.25 cr
GRAVITON RESEARCH CAPITAL LLP	08 Feb 2024	buy	₹ 522.39	1.35 lac	₹ 7.07 cr
GRAVITON RESEARCH CAPITAL LLP	08 Feb 2024	sell	₹ 522.27	1.35 lac	₹ 7.07 cr
GRAVITON RESEARCH CAPITAL LLP	02 Jan 2024	buy	₹ 517.17	4.10 lac	₹ 21.19 cr
GRAVITON RESEARCH CAPITAL LLP	02 Jan 2024	sell	₹ 517.50	4.10 lac	₹ 21.20 cr
JAINAM BROKING LIMITED	02 Jan 2024	buy	₹ 511.50	1.50 lac	₹ 7.67 cr
JAINAM BROKING LIMITED	02 Jan 2024	sell	₹ 520.70	96.13 k	₹ 5.01 cr

Corporate Actions

History of Windlas Biotech Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 6.30/share
Record date: 16th Jul 2026Ex-date: 16th Jul 2026
Announced on: 21st May 2026
Others
Ex-date: 24th Apr 2026Announced on: 17th Apr 2026
On Market Tender offer.
Dividend₹ 5.80/share
Record date: 21st Jul 2025Ex-date: 21st Jul 2025
Announced on: 22nd May 2025
Dividend₹ 5.50/share
Record date: 17th Sep 2024Ex-date: 17th Sep 2024
Announced on: 20th May 2024
Dividend₹ 4/share
Record date: 5th Sep 2023Ex-date: 5th Sep 2023
Announced on: 5th May 2023

Company Profile

Overview of Windlas Biotech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufactu...

Incorporated on

19 Feb 2001

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

1,385

IPO date

16 Aug 2021

Free Float

69,71,739

Website

https://windlas.com/

Phone no.

+911242821030

Address

705-706, Vatika Professional Point, Sector-66 Golf Course Extension Road, GURGAON, 122001, India

Frequently Asked Questions

What is the current share price of Windlas Biotech Ltd.?

The current share price of Windlas Biotech Ltd. is ₹ 945.40 as of 12 Oct 2026.

What is the market capitalisation of Windlas Biotech Ltd.?

The market capitalisation of Windlas Biotech Ltd. stands at ₹ 1,958.77 Cr.

What is the PE ratio of Windlas Biotech Ltd.?

The Price-to-Earnings (PE) ratio of Windlas Biotech Ltd. is 29.48 as of the latest trailing twelve months data.

What is the ROE and ROCE of Windlas Biotech Ltd.?

Windlas Biotech Ltd. has a Return on Equity (ROE) of 12.23% and a Return on Capital Employed (ROCE) of 12.82% as per the latest financial reports.

What is the 52-week high and low of Windlas Biotech Ltd.?

The 52-week high of Windlas Biotech Ltd. is - and the 52-week low is -.

What is the dividend yield of Windlas Biotech Ltd.?

The dividend yield of Windlas Biotech Ltd. is 0.66% based on the current market price.

What is the FII and DII holding in Windlas Biotech Ltd.?

Foreign Institutional Investors (FII) hold 2.04%, Domestic Institutional Investors (DII) hold 5.76% and retail/public investors hold 23.45% of Windlas Biotech Ltd. shares.

What sector does Windlas Biotech Ltd. belong to?

Windlas Biotech Ltd. operates in the Healthcare sector.

What is the beta of Windlas Biotech Ltd.?

The beta of Windlas Biotech Ltd. is 0.70, indicating its price volatility relative to the broader market. Over the past 1 year, Windlas Biotech Ltd. has delivered an absolute return of 0.85%.

What is the RSI of Windlas Biotech Ltd.?

The 14-day Relative Strength Index (RSI) of Windlas Biotech Ltd. is 32.08, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Windlas Biotech Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Windlas Biotech Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Holdings and Presence

Company Profile